You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 1, January 11, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Significant Weight Gain With Rezulin Therapy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A 62-year-old man developed type 2 diabetes mellitus circa 1994. He was initially treated with glyburide and then with insulin. After rezulin (initial dosage, 200 mg/d; later dosage, 400 mg/d) was added to the regimen,the percentage of glycosylated hemoglobin decreased from 9.5% to 6.7% (reference range, 4.1%-6.1%). Four months after the patient started taking 400 mg/d of rezulin, he began to develop peripheral edema and his waist circumference increased. Despite the initiation of furosemide therapy (40 mg/d), he gained a total of 20 kg over approximately 4 months.

He was admitted to the hospital because of increasing peripheral edema and shortness of breath. The physical examination revealed that the patient weighed 150 kg, that his blood pressure was normal, and that he had chronic atrial fibrillation. There were no rales or S3 gallop. There was 3 to 4+ pitting edema of the lower extremities, as well as stasis dermatitis.

The . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure
Tang et al.
J Am Coll Cardiol 2003;41:1394-1398.
ABSTRACT | FULL TEXT  

Combination Therapy With Nateglinide and a Thiazolidinedione Improves Glycemic Control in Type 2 Diabetes
Rosenstock et al.
Diabetes Care 2002;25:1529-1533.
ABSTRACT | FULL TEXT  

Deterioration of Rheumatoid Arthritis With Troglitazone: A Rare and Unexpected Adverse Effect
Sakurai and Hashizume
Arch Intern Med 2000;160:118-119.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.